ArticleAnnals of surgical oncology2026
Decision Regret and Burden in Caregivers of Patients with Appendiceal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Experiences and Decisional Outcomes After Cytoreductive Surgery for Peritoneal Surface Malignancy: The DECISIVE Study.Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInformal caregivers of patients with appendiceal cancer (AC) undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) may experience physical and psychological distress. The aim of this study was to determine the incidence of burden and decision regret among caregivers of patients with AC who underwent CRS-HIPEC. PATIENTS AND
methodsAn anonymous, IRB-exempt survey was administered to caregivers of patients with AC who underwent CRS-HIPEC. The primary outcome was caregiver burden (ZBI-12 survey). Secondary outcomes were assessed with the Decision Regret Scale (DRS), PROMIS-29 v 2.0 for quality of life (QOL), and the FACIT-COST for financial toxicity (FT).
resultsA total of 34 caregivers were included. The mean ZBI-12 score was 16 (IQR 9.5-22.5), which has been described as a meaningful cutoff for high burden. There were no major demographics or tumor characteristic differences between high and low burden groups. The most common burdens were feeling stressed caring for their family member (58.8%) and feeling they had lost control of their life since their relative's illness (26.5%). Caregiver burden was significantly related to increased decision regret (R = 0.399, p = 0.019). Higher FT was seen in incomplete surgical debulking (58.3% in the high FT group versus 0%; p = 0.005) and patients and caregivers who traveled ≥ 50 miles to the CRS-HIPEC center.
conclusionsHalf of caregivers reported high burden, which was associated with worse QOL and regret. Future studies will explore opportunities to improve support and resources for caregivers of patients undergoing CRS-HIPEC, both perioperatively and in the long-term.
Indexed as
Identifiers
41042467What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.